Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain
the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in
Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles
and JavaScript.
A single dose of an adenine base editor shows promise in treating the ageing-related disease Hutchinson–Gilford progeria syndrome. It corrected the LMNA mutation underlying the disease in patient-derived cells and improved cardiovascular health and lifespan in mice.
Is a trend of auctioning non-fungible tokens based on scientific data a fascinating art fad, an environmental disaster or the future of monetized genomics?
Scientists are searching for explanations to disappointing final-stage trial results. These insights could help guide the future development of mRNA vaccines.
An innovative approach to a phase II clinical trial aims to test the effects of multiple targeted treatments simultaneously in participants in the UK National Lung Matrix Trial. The design makes it possible to study small numbers of people with rare mutations in non-small-cell lung tumours.
Why humans need to drink more water than most mammals, why dust clouds follow the Mars helicopter and disappointing news from trials of the CureVac COVID-19 vaccine.
Cosmic-ray particles and γ-rays striking superconducting circuits can generate qubit errors that are spatially correlated across several millimetres, hampering current error-correction approaches.
